Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Asami Koyama"'
Publikováno v:
FEBS Open Bio, Vol 10, Iss 8, Pp 1532-1541 (2020)
Thioredoxin‐interacting protein (TXNIP) has been widely recognized as a tumor suppressor in various cancers, including liver, breast, and thyroid cancers. Although TXNIP is epigenetically silenced in acute myeloid leukemia (AML) cells, as in many c
Externí odkaz:
https://doaj.org/article/1059af73f9b144e696e9d2e024728cb7
Autor:
Tatsuya Masuda, Shintaro Maeda, Sae Shimada, Naoya Sakuramoto, Ken Morita, Asami Koyama, Kensho Suzuki, Yoshihide Mitsuda, Hidemasa Matsuo, Hirohito Kubota, Itaru Kato, Kuniaki Tanaka, Junko Takita, Masahiro Hirata, Tatsuki R Kataoka, Tatsutoshi Nakahata, Souichi Adachi, Hideyo Hirai, Shuichi Mizuta, Kazuhito Naka, Yoichi Imai, Shinya Kimura, Hiroshi Sugiyama, Yasuhiko Kamikubo
Publikováno v:
Cancer Science. 113(2):529-539
The emergence of tyrosine kinase inhibitors as part of a front-line treatment has greatly improved the clinical outcome of the patients with Ph⁺ acute lymphoblastic leukemia (ALL). However, a portion of them still become refractory to the therapy m
Autor:
Yasuhiko Kamikubo, Souichi Adachi, Yoko Nishinaka-Arai, Mina Noura, Yukiko Okuno, Asami Koyama, Hiroki Kiyose, Ken Morita, Hidemasa Matsuo
Publikováno v:
British Journal of Haematology. 194:598-603
Differentiation therapy is a less toxic but still a very effective treatment for a subset of acute myeloid leukaemia (AML) cases. With the goal to identify novel compounds that can effectively and safely induce the terminal differentiation of non-acu
Publikováno v:
FEBS Open Bio, Vol 10, Iss 8, Pp 1532-1541 (2020)
FEBS Open Bio
FEBS Open Bio
Thioredoxin‐interacting protein (TXNIP) has been widely recognized as a tumor suppressor in various cancers, including liver, breast, and thyroid cancers. Although TXNIP is epigenetically silenced in acute myeloid leukemia (AML) cells, as in many c
Autor:
Asami Koyama, Yasuhiko Kamikubo, Yutarou Harata, Moe Higashitani, Hidemasa Matsuo, Kana Nakatani, Mina Noura, Souichi Adachi, Yoko Nishinaka-Arai
Publikováno v:
International journal of hematology. 113(2)
The t(8;21) translocation is the most common cytogenetic abnormality in acute myeloid leukemia (AML). Although t(8;21) AML patients have a relatively favorable prognosis, relapse is a frequent occurrence, underscoring the need to develop novel therap
Autor:
Masuda, Tatsuya, Maeda, Shintaro, Shimada, Sae, Sakuramoto, Naoya, Morita, Ken, Koyama, Asami, Suzuki, Kensho, Mitsuda, Yoshihide, Matsuo, Hidemasa, Kubota, Hirohito, Kato, Itaru, Tanaka, Kuniaki, Takita, Junko, Hirata, Masahiro, Kataoka, Tatsuki R, Nakahata, Tatsutoshi, Adachi, Souichi, Hirai, Hideyo, Mizuta, Shuichi, Naka, Kazuhito
Publikováno v:
Cancer Science; Feb2022, Vol. 113 Issue 2, p529-539, 11p
Autor:
Noura, Mina, Morita, Ken, Kiyose, Hiroki, Okuno, Yukiko, Matsuo, Hidemasa, Koyama, Asami, Nishinaka‐Arai, Yoko, Kamikubo, Yasuhiko, Adachi, Souichi
Publikováno v:
British Journal of Haematology; Aug2021, Vol. 194 Issue 3, p598-603, 6p
Autor:
Nakatani, Kana, Matsuo, Hidemasa, Harata, Yutarou, Higashitani, Moe, Koyama, Asami, Noura, Mina, Nishinaka-Arai, Yoko, Kamikubo, Yasuhiko, Adachi, Souichi
Publikováno v:
International Journal of Hematology; 2021, Vol. 113 Issue 2, p243-253, 11p
Publikováno v:
FEBS Open Bio; Aug2020, Vol. 10 Issue 8, p1532-1541, 10p